Both CD56−CD16+ and CD56+CD16− NK cells again expanded and proliferated following re-infection (Figures 5C,D), with some increase in T cell numbers and marked residual T cell proliferation (Ki67+) despite anti-CD3 immunotoxin administration. This evidence concerns the gene NCAM1 and infection.